Aprepitant continues to be revealed to inhibit the two the acute and delayed emesis induced by cytotoxic chemotherapeutic medicines by blocking substance P landing on receptors from the brain's neurons. Positron emission tomography (PET) studies, have shown that aprepitant can cross the blood brain barrier and bind to NK1 receptors https://philx111kvg2.blog4youth.com/profile